Implications Of External Price Referencing of Pharmaceuticals in Middle East Countries.

Kalo, Z; Alabbadi, I; Al, Ahdab O G; Al-Badriyeh, D; Alowayesh, M; Al-Saggabi, A H; Elmahdawy, M; Tanzi, V L; Alsultan, H; Akhras, K; Kanavos, P

Kalo, Z; Alabbadi, I; Al, Ahdab O G; Al-Badriyeh, D; Alowayesh, M; Al-Saggabi, A H; Elmahdawy, M; Tanzi, V L; Alsultan, H; Akhras, K; Kanavos, P.

Afiliación

Kalo Z; Eötvös Loránd University (ELTE), Budapest, Hungary.
Alabbadi I; University of Jordan, Amman, Jordan.
Al AO; Ministry of Health, Abu Dhabi, United Arab Emirates.
Al-Badriyeh D; College of Pharmacy, Qatar University, Doha, Qatar.
Alowayesh M; Kuwait University, Yarmook, Kuwait.
Al-Saggabi AH; Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Elmahdawy M; Ministry of Health, Cairo, Egypt.
Tanzi VL; American University of Beirut, Beirut, Lebanon.
Alsultan H; Dasman Diabetes Institute, Yarmook, Kuwait.
Akhras K; Novartis, Dubai, United Arab Emirates.
Kanavos P; London School of Economics and Political Science, London, UK.

Value Health ; 17(7): A409, 2014 Nov.

Article en En | MEDLINE | ID: mdl-27201002

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Health_economic_evaluation Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google